|Articles|August 3, 2022
How Decentralized Trials Accelerate Research and Enable Diversity
Author(s)Science 37
Decentralized clinical trials are not an all-or-nothing approach, they encompass a spectrum of hybrid designs that when implemented correctly deliver transformative results. In this white paper, Science 37 leaders discuss where decentralized research is now, and where we are headed. Experts unveil new—and proven— models and the benefits they deliver, from accelerated patient enrollment and improved experience to real-world representation.
Trending on Applied Clinical Trials Online
1
Syneos Health Expands AI Ecosystem With Three New Platform Partnerships
2
Curavit Acquires Lindus Health Clinical Research Organization Assets to Expand US and European Trial Operations
3
When the Slack Runs Out: AI and the CRO Operating Model
4
ACT Brief: Trial Failures as Administrative Problems, CRO Consolidation for Global Trial Reach, and FDA Approval of First FOP Treatment
5